Q&A: Prostate and Gynecologic
Q&A Session for Gastrointestinal with Dr. Nguyen, Dr. Kirsch, and Dr. Albuquerque
The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Moderator: Beth Erickson, MD, FASTRO is employed by Medical College of Wisconsin and has no other disclosures to declare.
Paul Nguyen, MD, is employed by Brigham and Women’s Hospital and receives compensation/remuneration/funding from Astellas, Augmenix, Boston-Seientific, Cota, and Janssen.
Kevin Albuquerque, MD, is employed by UT Southwestern and has no other disclosures to declare.
David Kirsch, MD, PhD, FASTRO is employed by Duke University and receives compensation/remuneration/funding from GlaxoSmithKline, Lumicell Diagnostics, Merck and XRAD Therapeutics and has ownership or investment interest in Lumicell Diagnostics, and XRAD Therapeutics.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 0.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 Certificate of AttendanceThis activity was designated for 0.50 AMA PRA Category 1 Credit™.